Unknown Organization (20240257058). BUSINESS-TO-BUSINESS SYSTEM FOR PROMOTING AND OPTIMIZING DIVERSITY IN A CLINICAL RESEARCH SETTING simplified abstract

From WikiPatents
Jump to navigation Jump to search

BUSINESS-TO-BUSINESS SYSTEM FOR PROMOTING AND OPTIMIZING DIVERSITY IN A CLINICAL RESEARCH SETTING

Organization Name

Unknown Organization

Inventor(s)

RUQAYYAH Abdulrahoof of Los Angeles CA (US)

BUSINESS-TO-BUSINESS SYSTEM FOR PROMOTING AND OPTIMIZING DIVERSITY IN A CLINICAL RESEARCH SETTING - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240257058 titled 'BUSINESS-TO-BUSINESS SYSTEM FOR PROMOTING AND OPTIMIZING DIVERSITY IN A CLINICAL RESEARCH SETTING

Simplified Explanation:

The patent application discloses a B2B marketplace software system designed to increase diversity in the clinical research and development workforce, leading to more diverse clinical trials. This system connects biotechnology, biopharmaceutical, medical device, health tech, and other relevant companies with qualified clinical research suppliers and diverse talent, while reducing recruitment costs and providing more opportunities for industry suppliers.

  • Key Features and Innovation:
   - Connects companies with qualified clinical research suppliers
   - Connects diverse talent with relevant companies
   - Reduces recruitment costs for companies
   - Provides more opportunities for industry suppliers
  • Potential Applications:
   - Increasing diversity in clinical trials
   - Improving trust within diverse communities
   - Enhancing the quality and inclusivity of clinical research and development workforce
  • Problems Solved:
   - Lack of diversity in clinical trials
   - Limited trust within diverse communities
   - High recruitment costs for companies
   - Limited opportunities for industry suppliers
  • Benefits:
   - Increased diversity in clinical trials
   - Improved trust within diverse communities
   - Cost savings for companies
   - Enhanced opportunities for industry suppliers
  • Commercial Applications:
   - The software system can be used by biotechnology, biopharmaceutical, medical device, health tech, and other relevant companies to improve diversity in their clinical research and development workforce, leading to more inclusive and effective clinical trials.
  • Prior Art:
   - Readers can start their search for prior art related to this technology by looking into existing B2B marketplace software systems in the healthcare and life sciences industries.
  • Frequently Updated Research:
   - Stay informed about the latest developments in diversity initiatives in clinical research and development, as well as advancements in B2B marketplace software systems.

Questions about B2B Marketplace Software System for Increasing Diversity Among the Clinical Research and Development Workforce and Trust Within Diverse Communities:

1. How does the B2B marketplace software system contribute to increasing diversity in clinical trials?

   - The system connects companies with a diverse pool of qualified talent and clinical research suppliers, leading to more inclusive clinical trials.

2. What are the potential benefits of reducing recruitment costs for companies in the healthcare and life sciences industries?

   - By cutting recruitment costs, companies can allocate resources more efficiently and invest in other areas of their business, ultimately improving their overall competitiveness.


Original Abstract Submitted

a b2b marketplace software system for increasing diversity among the clinical research and development workforce and trust within diverse communities resulting in diverse clinical trials is disclosed. the b2b marketplace software system is configured to connect biotechnology/biopharmaceutical/medical device/health tech and other relevant companies with a pool of qualified clinical research suppliers; connect a diverse pool of qualified talent with biotechnology/biopharmaceutical/medical device/health tech and other relevant companies; cut talent recruitment and supplier discovery costs for biotechnology/biopharmaceutical/medical device/health tech and other relevant companies; and connect industry suppliers with more opportunities.